Autism Spectrum Disorder and Psychiatric Comorbidity in a Patient with Myhre Syndrome
Myhre syndrome (MS) is a connective tissue disorder with multisystem involvement with or without intellectual disability. In most cases SMAD4 mutations are reported. To date, 55 individuals have been molecularly confirmed. Autism has been proposed among associate clinical features of MS but no standardized diagnosis was available in previous cases. We report a case of a 25-year-old man with a pathogenic heterozygous SMAD4 missense mutation affecting residue Arg496 (SMAD4:p.Arg496Cys). Clinical findings are consistent with MS, commorbid with affective disorder and High Functioning Autism Spectrum Disorder confirmed by a standardized assessment procedure. The thorough clinical assessment of cases with syndromes such as MS can extend our knowledge on both the phenotypic characteristics of the syndrome and the genetic basis of autism.
KeywordsMyhre syndrome SMAD4 mutation High functioning autism spectrum disorder Affective disorder
We need to acknowledge the patient and his family as well as Dr A. Anastasakis Cardiologist and Dr K. Markoglou Gastroenterologist for their kind contribution to the collection of data.
PA conceived of the study, drafted the manuscript, SA conceived of the study, helped to draft the manuscript, PK conceived of the study, drafted the manuscript, FH conceived of the study, helped to draft the manuscript, TE conceived of the study, helped to draft the manuscript and PC conceived of the study, helped to draft the manuscript.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Additional informed consent was obtained from the participant for whom identifying information is included in this article.
- Le Couteur, A., Lord, C., & Rutter, M. (2003). The autism diagnostic interview—revised (ADI-R). Los Angeles, CA: Western Psychological Services.Google Scholar
- Lelieveld, S. H., Wiel, L., Venselaar, H., Pfundt, R., Vriend, G., Veltman, J. A., et al. (2017). Spatial clustering of de Novo Missense mutations identifies candidate neurodevelopmental disorder-associated genes. American Journal of Human Genetics, 101(3), 478–487.CrossRefPubMedPubMedCentralGoogle Scholar
- Lin, E., Michot, A. C., Cormier-Daire, V., L’Ecuyer, T. J., MatherneG, P., BarnesH, B., et al. (2016). Gain of function mutations in SMAD4 cause a distinctive repertoire of cardiovascular phenotypes in patients with Myhre syndrome. American Journal of Medical Genetics, 170A, 2617–2631.CrossRefGoogle Scholar
- Lord, C., Rutter, M., DiLavore, P. C., Risi, S., Gotham, K., Bishop, S. L., et al. (2012). Autism diagnostic observation schedule (2nd ed.). Torrance, CA: Western Psychological Services.Google Scholar
- Papanikolaou, K., Paliokosta, E., Houliaras, G., Vgenopoulou, S., Giouroukou, E., Pehlivanidis, A., et al. (2009). Using the autism diagnostic interview: Revised and the autism diagnostic observation schedule-generic for the diagnosis of autism spectrum disorders in a Greek sample with a wide range of intellectual abilities. Journal of Autism and Developmental Disorders, 39(4), 414–420.CrossRefPubMedGoogle Scholar
- Piccolo, P., Mithbaokar, P., Sabatino, V., Tolmie, J., Melis, D., Schiaffino, M. C., et al. (2014). SMAD4 mutations causing Myhre syndrome result in disorganization of extracellular matrix improved by losartan. European Journal of Human Genetics, 22, 988–994.CrossRefPubMedPubMedCentralGoogle Scholar
- Starr, L. J., Lindor, N. M., & Lin, A. E. (2017). Myhre syndrome. Seattle: University of Washington.Google Scholar
- Titomanlio, L., Marzano, M. G., Rossi, E., D’Armiento, M., De Brasi, D., Vega, G. R., et al. (2001). Case of Myhre syndrome with autism and peculiar skin histological findings. American Journal of Human Genetics, 103, 163–165.Google Scholar